ABCELLERA BIOLOGICS Cash Flow Reinvestment Rate
ABCELLERA BIOLOGICS cash flow reinvestment rate. ABCELLERA BIOLOGICS (8QQ) has a Cash Flow Reinvestment Rate of 0.39x as of June 2026, reinvesting €10.01 Million (capex €2.13 Million plus investments €7.88 Million) from operating cash flow of €25.92 Million. Explore ABCELLERA BIOLOGICS (8QQ) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ABCELLERA BIOLOGICS (2021–2022)
Cash flow reinvestment rate of ABCELLERA BIOLOGICS from 2021 to 2022. Historical reinvestment intensity for ABCELLERA BIOLOGICS across 2 annual periods. Explore 8QQ capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
ABCELLERA BIOLOGICS Cash Flow Reinvestment Rate by Year (2021–2022)
ABCELLERA BIOLOGICS cash flow reinvestment rate by year from 2021 to 2022. Year-by-year capital reinvestment analysis for ABCELLERA BIOLOGICS. For the full cash flow conversion analysis, see ABCELLERA BIOLOGICS cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.24x | €343.38 Million | €277.36 Million | €72.66 Million | ▼ -6.3% |
| 2021 | 1.32x | €323.09 Million | €244.58 Million | €58.45 Million | — |